Bradykinin B2 Receptor Antagonist class drugs

2 results

Firazyr (icatibant acetate)

(icatibant acetate)
Takeda Pharmaceuticals America, Inc.
Usage: FIRAZYR® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years and older.
Alembic Pharmaceuticals Inc.
Usage: Icatibant injection is indicated for treating acute attacks of hereditary angioedema (HAE) in adults aged 18 years and older.